Friends 2019 Annual Meeting Panel 3 - Data Generation (and Review Considerations) for Use of a Companion Diagnostic for a Group of Oncology Therapeutic Products
Friends 2019 Annual Meeting Panel 2 - Immuno-Oncology Combination Drug Development for Patients with Disease Progression After Initial anti-PD-(L)1 Therapy